TY - JOUR
T1 - ImPlementation REsearCh to DEvelop Interventions for People Living with HIV (the PRECluDE consortium)
T2 - Combatting chronic disease comorbidities in HIV populations through implementation research
AU - Implementation Research to Develop Interventions for People Living with HIV (PRECluDE) Consortium
AU - Gamble-George, Joyonna Carrie
AU - Longenecker, Christopher T.
AU - Webel, Allison R.
AU - Au, David H.
AU - Brown, Arleen F.
AU - Bosworth, Hayden
AU - Crothers, Kristina
AU - Cunningham, William E.
AU - Fiscella, Kevin A.
AU - Hamilton, Alison B.
AU - Helfrich, Christian D.
AU - Ladapo, Joseph A.
AU - Luque, Amneris
AU - Tobin, Jonathan N.
AU - Wyatt, Gail E.
N1 - Publisher Copyright:
© 2020
PY - 2020/3/1
Y1 - 2020/3/1
N2 - Antiretroviral therapy (ART) prevented premature mortality and improved the quality of life among people living with the human immunodeficiency virus (PLWH), such that now more than half of PLWH in the United States are 50 years of age and older. Increased longevity among PLWH has resulted in a significant rise in chronic, comorbid diseases. However, the implementation of guideline-based interventions for preventing, treating, and managing such age-related, chronic conditions among the HIV population is lacking. The PRECluDE consortium supported by the Center for Translation Research and Implementation Science at the National Heart, Lung, and Blood Institute catalyzes implementation research on proven-effective interventions for co-occurring heart, lung, blood, and sleep diseases and conditions among PLWH. These collaborative research studies use novel implementation frameworks with HIV, mental health, cardiovascular, and pulmonary care to advance comprehensive HIV and chronic disease healthcare in a variety of settings and among diverse populations.
AB - Antiretroviral therapy (ART) prevented premature mortality and improved the quality of life among people living with the human immunodeficiency virus (PLWH), such that now more than half of PLWH in the United States are 50 years of age and older. Increased longevity among PLWH has resulted in a significant rise in chronic, comorbid diseases. However, the implementation of guideline-based interventions for preventing, treating, and managing such age-related, chronic conditions among the HIV population is lacking. The PRECluDE consortium supported by the Center for Translation Research and Implementation Science at the National Heart, Lung, and Blood Institute catalyzes implementation research on proven-effective interventions for co-occurring heart, lung, blood, and sleep diseases and conditions among PLWH. These collaborative research studies use novel implementation frameworks with HIV, mental health, cardiovascular, and pulmonary care to advance comprehensive HIV and chronic disease healthcare in a variety of settings and among diverse populations.
KW - Antiretroviral therapy
KW - COPD
KW - Cardiovascular disease
KW - Comorbidities
KW - HIV
KW - Implementation science
UR - http://www.scopus.com/inward/record.url?scp=85083529069&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85083529069&partnerID=8YFLogxK
U2 - 10.1016/j.pcad.2020.03.006
DO - 10.1016/j.pcad.2020.03.006
M3 - Review article
C2 - 32199901
AN - SCOPUS:85083529069
SN - 0033-0620
VL - 63
SP - 79
EP - 91
JO - Progress in Cardiovascular Diseases
JF - Progress in Cardiovascular Diseases
IS - 2
ER -